Quinupristin/dalfopristin in Staphylococcus aureus endophthalmitis: a case report
<p>Abstract</p> <p>Introduction</p> <p>The intravitreal injection of antibiotics remains the mainstay of therapy for postoperative endophthalmitis. Bacterial resistance, however, is still a pitfall in achieving an adequate response to treatment. Quinupristin/dalfopristi...
Main Author: | Hernandez-Da Mota Sergio E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/130 |
Similar Items
-
Safety of intravitreal quinupristin/dalfopristin in an animal model
by: Veronica E. Giordano, et al.
Published: (2016-03-01) -
Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin
by: Fucini Paola, et al.
Published: (2004-04-01) -
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
by: Kanchanapoom Termkiat, et al.
Published: (2005-01-01) -
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
by: Aref Shariati, et al.
Published: (2020-04-01) -
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the Global SMART (GSMART) surveillance study
by: Sader Helio S., et al.
Published: (2001-01-01)